Performance evaluation of a CRISPR Cas9-based selective exponential amplification assay for the detection of KRAS mutations in plasma of patients with advanced pancreatic cancer
Yue Shen(Tianjin University), Jinzhao Song(Tianjin University), Yuhua Zhang(State Key Laboratory of Digital Medical Engineering), Xiaoling Zhang(Shaoxing University), Qinglin Li(Sinopec (China)), Li-Yi Zhang(Institute of Pomology), Bao Lyu(Chinese Academy of Sciences), Zuoying Zhang(Tianjin University), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 10
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412